News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,139 Results
Type
Article (14136)
Company Profile (282)
Press Release (250721)
Section
Business (79472)
Career Advice (152)
Deals (13224)
Drug Delivery (35)
Drug Development (50415)
Employer Resources (32)
FDA (5707)
Job Trends (5125)
News (144324)
Policy (10027)
Tag
Academia (906)
Alliances (21617)
Alzheimer's disease (805)
Antibody-drug conjugate (ADC) (79)
Approvals (5713)
Artificial intelligence (99)
Bankruptcy (102)
Best Places to Work (4560)
Biotechnology (232)
Breast cancer (132)
Cancer (1160)
Cardiovascular disease (92)
Career advice (132)
CAR-T (100)
Cell therapy (290)
Clinical research (40642)
Collaboration (459)
Compensation (188)
COVID-19 (1028)
C-suite (127)
Cystic fibrosis (75)
Data (1198)
Diabetes (110)
Diagnostics (1283)
Earnings (29343)
Events (47837)
Executive appointments (372)
FDA (6246)
Funding (428)
Gene editing (79)
Gene therapy (210)
GLP-1 (341)
Government (1072)
Healthcare (6580)
Infectious disease (1082)
Inflammatory bowel disease (106)
IPO (7252)
Job creations (859)
Job search strategy (127)
Layoffs (197)
Legal (1384)
Lung cancer (165)
Manufacturing (105)
Medical device (2582)
Medtech (2583)
Mergers & acquisitions (6217)
Metabolic disorders (330)
Neuroscience (1135)
NextGen: Class of 2025 (2015)
Non-profit (853)
Northern California (1401)
Obesity (171)
Opinion (99)
Parkinson's disease (91)
Patents (95)
People (25402)
Phase I (14346)
Phase II (18907)
Phase III (11949)
Pipeline (566)
Postmarket research (852)
Preclinical (6012)
Radiopharmaceuticals (210)
Rare diseases (256)
Real estate (1414)
Regulatory (8483)
Research institute (935)
Series A (85)
Southern California (1242)
Startups (1970)
United States (11038)
Vaccines (193)
Weight loss (97)
Date
Today (134)
Last 7 days (498)
Last 30 days (1687)
Last 365 days (20400)
2025 (3294)
2024 (20553)
2023 (22415)
2022 (26823)
2021 (27805)
2020 (23357)
2019 (16225)
2018 (11739)
2017 (13746)
2016 (11841)
2015 (14351)
2014 (10395)
2013 (7486)
2012 (7532)
2011 (7615)
2010 (7429)
Location
Africa (148)
Asia (17129)
Australia (2899)
California (3191)
Canada (988)
China (284)
Colorado (123)
Connecticut (135)
Delaware (77)
Europe (36845)
Florida (371)
Georgia (94)
Illinois (198)
Indiana (78)
Maryland (413)
Massachusetts (2528)
Minnesota (124)
New Jersey (798)
New York (878)
North Carolina (491)
Northern California (1401)
Ohio (102)
Pennsylvania (598)
South America (207)
Southern California (1242)
Texas (354)
Washington State (298)
265,139 Results for "pendulum therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules
Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.
February 24, 2025
·
6 min read
·
Christian Antoni
Business
Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer
Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.
January 9, 2024
·
5 min read
Biotech Bay
Halle Berry, Long-Standing Pendulum Customer, Joins Company as Chief Communications Officer, and Becomes Equity Owner and Investor
Pendulum Therapeutics announced that Halle Berry, Academy Award® winning actress and director, has joined the company as equity owner, investor and Chief Communications Officer.
February 9, 2023
·
4 min read
Biotech Bay
Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila, a Key Strain Forging a Path for the Future of Probiotics
Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila , a Key Strain Forging a Path for the Future of Probiotics.
June 10, 2022
·
2 min read
Biotech Bay
Pendulum Therapeutics Provides Leadership in Microbiome Education among Healthcare Professionals
Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the microbiome and its relationship to metabolic disease, including type 2 diabetes.
October 28, 2021
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Biotech Bay
Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes
Pendulum Therapeutics , a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced today the launch of Pendulum Glucose Control, the first and only medical probioti
June 4, 2020
·
5 min read
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Pharm Country
NAD Finds Health-Related Claims for Pendulum Glucose Control Medical Probiotic Supported but Recommends Some Modifications
The National Advertising Division (NAD) of BBB National Programs determined that certain claims for Pendulum Glucose Control, manufactured by Pendulum Therapeutics, Inc. to help Type 2 diabetes dietary management, were supported by competent and reliable scientific evidence:
March 3, 2021
·
3 min read
Business
Pendulum Therapeutics Announces Formation of Scientific and Medical Advisory BoardsGlobally Recognized Metabolic Experts and Industry Luminaries Underscore Pendulum’s Foundation of Scientific Rigor and Medical Innovation
Pendulum Therapeutics, an evidence-based microbiome company, announced today the formation of its Scientific Advisory Board (SAB) and Medical Advisory Board (MAB).
January 21, 2020
·
5 min read
1 of 26,514
Next
